TIPE2 acts as a tumor suppressor and correlates with tumor microenvironment immunity in epithelial ovarian cancer

Shuai Xu(Washington University in St. Louis), Shiqian Zhang(Qilu Hospital of Shandong University), Fanzhen Hong(Second Hospital of Shandong University), Fufeng Gao(Shandong Tumor Hospital), Xia Wang(Qilu Hospital of Shandong University), Xiaolin Gao(Second Hospital of Shandong University), Jianqing Qiu(West China Medical Center of Sichuan University)
Aging
February 17, 2023
10.18632/aging.204529
Cited by 8

Related Papers

Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status
|JAMA Network Open|2024|121
Optimized Dynamic Network Biomarker Deciphers a High‐Resolution Heterogeneity Within Thyroid Cancer Molecular Subtypes
|Med Research|2025|80
Osteoclast regulation of osteoblasts via RANK-RANKL reverse signal transduction in vitro
|Molecular Medicine Reports|2017|55
Racial and Ethnic Differences in Rural-Urban Trends in 5-Year Survival of Patients With Lung, Prostate, Breast, and Colorectal Cancers: 1975-2011 Surveillance, Epidemiology, and End Results (SEER)
|JAMA Network Open|2022|50
Metabolic engineering of<i>Zymomonas mobilis</i>for continuous co-production of bioethanol and poly-3-hydroxybutyrate (PHB)
|Green Chemistry|2022|41